-
1 case of chronic inflammatory demyelinion-prone neuroroot neuropathy.
Time of Update: 2020-07-17
!---- male, 19 years old was admitted to hospital for "facial numbness, numbness in the limbs and inability to engage in sexual aggravation for more than 1 year" admission 15 months before no obviou
-
Cell: Small glial cells give way to space for new synaptic formations by devouring extracellular matrixes.
Time of Update: 2020-07-17
!--:page title"--July 12, 2020 // --- In order to create new memories, our brain cells must first find each other small protrusions protruding from the endof of the neurons' long branches of tentacle
-
Cell Metab: What brain cells cause our dependence on sugar?
Time of Update: 2020-07-17
!---- fibroblast growth factor 21 (FGF21) is an endocrine hormone produced by the liver that regulates nutritional and metabolic balance the production of FGF21 increases in the context of macronutri
-
Neuron. The Hong team reveals how neural networks in the brain recognize and encode gender.
Time of Update: 2020-07-17
however, how the neural information encoding gender is processed by the complex neural networks in the cerebral cortex, how it integrates with other information, and how it affects the behavior of animals remains to be studied.
-
Stroke: Identify the factors associated with neurological dysfunction in acute cerebral bridge infarction.
Time of Update: 2020-07-17
!---- The relationship between the infarction lesions and neurodysfunction in patients with acute cerebral bridge infarction is not clear study aims to identify morphological MRI predictions for earl
-
11 indications for 30 years! FDA approves AbbVie Botox bolibation: Treatment of lower limb spasms caused by cerebral palsy in children!
Time of Update: 2020-07-17
July 11, 2020 /PRNewswire/ -- AbbVie has announced that the U.S Food and Drug Administration (FDA) has approved a supplemental biologic licensing application (sBLA) to support the expansion of the use
-
New drug for cerebral palsy children's spasms! FDA approves Ipson Botox Dysport: Treatment of upper limb spasms caused by cerebral palsy in 2-year-old sepsis!
Time of Update: 2020-07-17
July 13, 2020 /PRNewswire/ -- Ipsen BioPharmaceuticals, a subsidiary of The French pharmaceutical company Ipsen, has announced that the U.S Food and Drug Administration (FDA) has approved the expansio
-
Inter J Geriatric Sieg: Prospective Cohort Study: Dementia Diagnosis Has New Biomarkers
Time of Update: 2020-07-16
!---- introduction: Alzheimer's has always been one of the unsolvable problems in the medical community the World Health Organization estimates that the total number of people with dementia will reac
-
Takayasu disease concurrent cobweb subcranial hemorrhage, cerebral infarction 1 case reported
Time of Update: 2020-07-16
!---- Takayasu disease (Takayasu arteritis, TA) is also known as veinless disease, an unexplained arteritis this paper reports on the complications of cobweb hypoliation bleeding and cerebral infarct
-
Stroke: How to accurately evaluate changes in intracranial hematoma?
Time of Update: 2020-07-16
!---- The definition of background and purpose hematoma enlargement focuses on changes in ventricular volume in-brain hemorrhage (IVH) is a predictor of poor prognosis, but IVH expansion is not inclu
-
Neurosurgery specialist Mao Ying was promoted to president of Huashan Hospital
Time of Update: 2020-07-16
On the morning !---- of July 14th, Huashan Hospital held a meeting of cadres to announce the decision on the appointment and removal of the hospital president , the Party Secretary of Fudan University
-
Stroke: Classification of ischemic stroke based on high-risk cervical artery plaques of non-conclinoe stenosis
Time of Update: 2020-07-16
!---- 50% of the background and objective cervical artery plaques and tube cavities may not be the main cause of the stroke mechanism this study to assess the value of reclassification of stroke by r
-
New Alzheimer's drug targeting A beta BAN2401, starts Phase III clinical study
Time of Update: 2020-07-16
Biogen and Eisai !---- announced the start of Phase 3 clinical studies on BAN2401 for the treatment of Alzheimer's disease (AD) BAN2401 is an antibody that is resistant to amyloid (A-beta) and is des
-
Stroke: By the time people reach middle age, what factors affect cognitive function?
Time of Update: 2020-07-16
!---- The relationship between hidden vascular brain injury and cognitive impairment in middle-aged population sourcing and cognitive impairment is not clear at present study to verify that patients
-
NAT COMMUN: Cytoskeleton-regulating proteins drive the occurrence of glioblastomas
Time of Update: 2020-07-16
glioblastoma is a deadly cancer !---- and there is no effective treatment to date we urgently need to better understand and identify selective targets recently, researchers found that advillin (AVIL
-
Neuron in situ regeneration promises to treat Parkinson's disease
Time of Update: 2020-07-15
At the same time, can damaged neuronal circuits be rebuilt?
-
Nature sub-magazine breakthrough! In-situ electrochemical produces nitric oxide, precisely regulating neurons!
Time of Update: 2020-07-15
, July 2, 2020 /PRNewswire /bio-valley/-- Nitric oxide is an important signaling molecule in the human body that plays a role in establishing neural system connections and helps with learning and me
-
Study reveals neural mechanisms of flexible action choice
Time of Update: 2020-07-15
recently, the Yao Haishan Research Group of the Center for Excellence in Brain Science and Intelligent Technology (Neuroscience Research Institute), Shanghai Brain Science and Brain Control Center,
-
What happens when the brain gets older? Nature's new discovery refreshes a century-old awareness
Time of Update: 2020-07-15
A research paper on the "blood-brain barrier" has recently been published in nature, a leading academic journal Scientists from Stanford University School of Medicine found a surprising phenomenon w
-
Nat Commun: A beta protein structure reveals its toxicity
Time of Update: 2020-07-15
, July 2, 2020 /PRNewswire/ --- -- The brains of millions of people with Alzheimer's disease (AD) are slowly and inevitably running out of neurons, leading to a characteristic loss of memory and cogn